{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:32Z","timestamp":1792511192207,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103082","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:18:14Z","timestamp":1790695094000},"page":"103082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Meng","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-4275","authenticated-orcid":false,"given":"Yuan-Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-3465","authenticated-orcid":false,"given":"Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103082_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.stem.2025.07.008","article-title":"A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy","volume":"32","author":"Li","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103082_bib2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","article-title":"Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103082_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41577-025-01229-3","article-title":"Microenvironmental regulation of solid tumour resistance to CAR T cell therapy","volume":"26","author":"Lamplugh","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103082_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41571-025-01035-9","article-title":"The next generation of immunotherapies for lung cancers","volume":"22","author":"Zhao","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103082_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412982","article-title":"Engineered bacteria manipulate cysteine metabolism to boost ferroptosis-based pancreatic ductal adenocarcinoma therapy","volume":"37","author":"Qiao","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103082_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103082_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2507711122","article-title":"Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment","volume":"122","author":"Yuan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103082_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt7298","article-title":"Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy","volume":"11","author":"Xie","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.103082_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009744","article-title":"Antibody engineered platelets attracted by bacteria-induced tumor-specific blood coagulation for checkpoint inhibitor immunotherapy","volume":"31","author":"Fan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.xcrm.2026.103082_bib10","article-title":"Engineered bacterial bioreactor for tumor therapy via Fenton-like reaction with localized H2O2 generation","volume":"31","author":"Fan","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103082_bib11","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3390\/cancers14133073","article-title":"BCG in bladder cancer immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2026.103082_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41551-025-01459-9","article-title":"Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis","volume":"10","author":"Iwata","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.103082_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103082_bib14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103082_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41551-024-01191-w","article-title":"Oncolytic mineralized bacteria as potent locally administered immunotherapeutics","volume":"8","author":"Wang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.103082_bib16","first-page":"759","article-title":"No excess cancer risk for non-erosive disease","volume":"20","author":"Barranco","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103082_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-024-03178-6","article-title":"Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma","volume":"43","author":"Luo","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103082_bib18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12672-025-03451-w","article-title":"Neutrophil extracellular traps in tumor metastasis: mechanisms, and therapeutic implications","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.xcrm.2026.103082_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103082_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202937","article-title":"Tumor cell-intrinsic SETD2 deficiency reprograms neutrophils to foster immune escape in pancreatic tumorigenesis","volume":"10","author":"Niu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.103082_bib21","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-07-2984","article-title":"Containment of tumor-colonizing bacteria by host neutrophils","volume":"68","author":"Westphal","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103082_bib22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.immuni.2025.05.001","article-title":"Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy","volume":"58","author":"Garcia Castillo","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103082_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acs.nanolett.0c03811","article-title":"\u201cTrojan horse\u201d salmonella enabling tumor homing of silver nanoparticles via neutrophil infiltration for synergistic tumor therapy and enhanced biosafety","volume":"21","author":"Mi","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.xcrm.2026.103082_bib24","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","article-title":"Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103082_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2025.109477","article-title":"The protective role of 3-Indoleglyoxylic acid in Bisphenol S-induced intestinal barrier dysfunction via mitochondrial ROS-Mediated IL-17\/CXCL10\/TNF-\u03b1 signaling","volume":"199","author":"Wang","year":"2025","journal-title":"Environ. Int."},{"key":"10.1016\/j.xcrm.2026.103082_bib26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41564-022-01196-8","article-title":"Multi-omics analyses of airway host\u2013microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions","volume":"7","author":"Yan","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2026.103082_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbi.2022.08.003","article-title":"Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP\/PS1 mice","volume":"106","author":"Sun","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.xcrm.2026.103082_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2377576","article-title":"Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.xcrm.2026.103082_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103082_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/08820139.2020.1787436","article-title":"Neutralization of TNF-\u03b1 and IL-1\u03b2 regulates CXCL8 production through CXCL8\/CXCR1 axis in macrophages during Staphylococcus aureus infection","volume":"50","author":"Dutta","year":"2021","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.xcrm.2026.103082_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","article-title":"Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer","volume":"10","author":"Liubomirski","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103082_bib32","article-title":"Targeting splenic myeloid cells with nanobiologics to prevent postablative pancreatic cancer recurrence via inducing antitumor peripheral trained immunity","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.103082_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1625114","article-title":"The role of inflammatory factors in the tumor microenvironment of pancreatic cancer","volume":"16","author":"Yuan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103082_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:14:16Z","timestamp":1792509256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126004994"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103082","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103082"}}